Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-05-24
1979-01-09
Marantz, Sidney
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 250458, 424 12, G01N 2152, G01N 3316
Patent
active
041338731
ABSTRACT:
Hepatitis associated antigen (HAA) in human blood serum is precipitated on HAA-specific antibodies immobilized on the inner wall of a plastic tube. A solution of HAA-specific antibodies tagged with fluorescein is held in contact with the deposited antigens until a portion of the antibodies from the solution is affixed to the antigens. The residual, tagged antibodies in the solution are exposed to a light pulse, and the resulting fluorescence is measured as an inverse indication of HAA in the blood serum.
REFERENCES:
patent: 3646346 (1972-02-01), Catt
patent: 3789116 (1974-01-01), Kay
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein
patent: 4020151 (1977-04-01), Bolz
Chemical Abstracts, 75:45466w (1971).
Berman Hans
Marantz Sidney
LandOfFree
Method of determining extracellular antigens and antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining extracellular antigens and antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining extracellular antigens and antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1788654